Clinical Utility of Liquid Biopsy in the Diagnosis and Monitoring of Patients Affected by PROS Syndromes

• E. Munera-Maravilla,
• C. Ortuño Moya,
• S. Gallach,
• C. Labrandero,
• A. Moreno-Manuel,
• M. Bellón-Robles,
• S. Calabuig-Fariñas,
• A. Esteve-Martínez,
• E. Jantus-Lewintre

Affiliations

E. Munera-Maravilla

Molecular Oncology Laboratory, General University Hospital of Valencia Research Foundation, Valencia, Spain; Unidad Mixta TRIAL CIPF-FIHGUV, Valencia, Spain; CIBERONC, Valencia, Spain

C. Ortuño Moya

Molecular Oncology Laboratory, General University Hospital of Valencia Research Foundation, Valencia, Spain; Unidad Mixta TRIAL CIPF-FIHGUV, Valencia, Spain

S. Gallach

Molecular Oncology Laboratory, General University Hospital of Valencia Research Foundation, Valencia, Spain; Unidad Mixta TRIAL CIPF-FIHGUV, Valencia, Spain

C. Labrandero

Dermatology Department, General University Hospital of Valencia, Valencia, Spain

A. Moreno-Manuel

Molecular Oncology Laboratory, General University Hospital of Valencia Research Foundation, Valencia, Spain; Unidad Mixta TRIAL CIPF-FIHGUV, Valencia, Spain; CIBERONC, Valencia, Spain

M. Bellón-Robles

Molecular Oncology Laboratory, General University Hospital of Valencia Research Foundation, Valencia, Spain; Unidad Mixta TRIAL CIPF-FIHGUV, Valencia, Spain

S. Calabuig-Fariñas

Molecular Oncology Laboratory, General University Hospital of Valencia Research Foundation, Valencia, Spain; Unidad Mixta TRIAL CIPF-FIHGUV, Valencia, Spain; CIBERONC, Valencia, Spain; Pathology Department, Universitat de València, Valencia, Spain

A. Esteve-Martínez

Dermatology Department, General University Hospital of Valencia, Valencia, Spain

E. Jantus-Lewintre

Molecular Oncology Laboratory, General University Hospital of Valencia Research Foundation, Valencia, Spain; Unidad Mixta TRIAL CIPF-FIHGUV, Valencia, Spain; CIBERONC, Valencia, Spain; Biotechnology Department, Valencia, Spain